Design considerations for Factorial Adaptive Multi-Arm Multi-Stage (FAST) clinical trials

• Published in: Current controlled trials in cardiovascular medicine Vol. 25; no. 1; pp. 608 - 8
• Main Authors: Beall, Jonathan, Elm, Jordan, Semler, Matthew W, Wang, Li, Rice, Todd, Kamel, Hooman, Mack, William, Mistry, Akshitkumar M
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 12.09.2024; BioMed Central; BMC
• Subjects: Adaptive design; Clinical trial; Clinical trials; Efficiency; Electrolytes; Factorial design; Fluids; Hemorrhage; Multi-arm; Multi-stage; Sodium
• ISSN: 1745-6215; 1745-6215
• DOI: 10.1186/s13063-024-08400-6

Abstract Background Multi-Arm, Multi-Stage (MAMS) clinical trial designs allow for multiple therapies to be compared across a spectrum of clinical trial phases. MAMS designs fall under several overarching design groups, including adaptive designs (AD) and multi-arm (MA) designs. Factorial clinical trials designs represent a combination of factorial and MAMS trial designs and can provide increased efficiency relative to fixed, traditional designs. We explore design choices associated with Factorial Adaptive Multi-Arm Multi-Stage (FAST) designs, which represent the combination of factorial and MAMS designs. Methods Simulation studies were conducted to assess the impact of the type of analyses, the timing of analyses, and the effect size observed across multiple outcomes on trial operating characteristics for a FAST design. Given multiple outcomes types assessed within the hypothetical trial, the primary analysis approach for each assessment varied depending on data type. Results The simulation studies demonstrate that the proposed class of FAST trial designs can offer a framework to potentially provide improvements relative to other trial designs, such as a MAMS or factorial trial. Further, we note that the design implementation decisions, such as the timing and type of analyses conducted throughout trial, can have a great impact on trial operating characteristics. Conclusions Motivated by a trial currently under design, our work shows that the FAST category of trial can potentially offer benefits similar to both MAMS and factorial designs; however, the chosen design aspects which can be included in a FAST trial need to be thoroughly explored during the planning phase.